Cathepsin L is highly expressed in gastrointestinal stromal tumors

International Journal of Oncology

Volumn 39, Issue 5, 2011, Pages 1109-1115

  Miyamoto, Kohtaro ^a   Iwadate, Manabu ^a   Yanagisawa, Yuka ^a   Ito, Emi ^a   Imai, Jun Ichi ^a   Yamamoto, Masaya ^a   Sawada, Naoki ^a   Saito, Motonobu ^a   Suzuki, Satoshi ^a   Nakamura, Izumi ^a   Ohki, Shinji ^a   Saze, Zenichiro ^a   Kogure, Michihiko ^a   Gotoh, Mitsukazu ^a   Obara, Kazutoshi ^a   Ohira, Hiromasa ^a   Tasaki, Kazuhiro ^a   Abe, Masafumi ^a   Goshima, Naoki ^b   Watanabe, Shinya ^a   Waguri, Satoshi ^a   Takenoshita, Seiichi ^a   more..

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

C kit; Cathepsin L; Cysteine proteinase; Gastrointestinal stromal tumors; Tumor marker

Indexed keywords

CATHEPSIN L; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MESSENGER RNA; TUMOR MARKER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CELL; CANCER RECURRENCE; CLINICAL ARTICLE; COLORECTAL TUMOR; CONTROLLED STUDY; CYTOPLASM; DISEASE MARKER; DOUBLE IMMUNOFLUORESCENCE MICROSCOPY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LYSOSOME; MALE; ONCOGENE C KIT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEX DIFFERENCE; STOMACH TUMOR; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CATHEPSIN L; FEMALE; GASTRIC MUCOSA; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MALE; MIDDLE AGED; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-KIT; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 80053196652     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1127     Document Type: Article

References (26)

1. Fletcher CD, Berman JJ, Corless C, et al: Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33: 459-465, 2002. (Pubitemid 34747864)
2. Kindblom LG, Remotti HE, Aldenborg F and Meis-Kindblom JM: Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 152: 1259-1269, 1998. (Pubitemid 28221878)
3. Hirota S, Isozaki K, Moriyama Y, et al: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279: 577-580, 1998. (Pubitemid 28067289)
4. Heinrich MC, Corless CL, Duensing A, et al: PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299: 708-710, 2003. (Pubitemid 36159485)
5. Miettinen M, Sobin LH and Sarlomo-Rikala M: Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with reference to CD117 (KIT). Mod Pathol 13: 1134-1142, 2000.
6. Heinrich MC, Corless CL, Demetri GD, et al: Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21: 4342-4349, 2003. (Pubitemid 46621810)
7. Demetri GD, Benjamin R, Blanke CD, et al: NCCN Task force report: optimal management of patients with gastrointestinal tumor (GIST) expansion and update of NCCN clinical practice guidelines. J Natl Compr Cancer Netw 2: S1-S26, 2004.
8. Barrett AJ and Kirschke H: Cathepsin B, cathepsin H and cathepsin L. Methods Enzymol 80: 535-561, 1981.
9. Mason RW, Johnson DA, Barrett AJ and Chapman HA: Elastinolytic activity of human cathepsin L. Biochem J 233: 925-927, 1986. (Pubitemid 16116171)
10. Chauhan S, Goldstein LJ and Gottesman MM: Expression of cathepsin L in human tumors. Cancer Res 51: 1478-1481, 1991.
11. Gal S and M Gottesman: The major excreted protein of transformed fibroblasts is an activatable acid-protease. J Biol Chem 261: 1760-1765, 1986. (Pubitemid 17205010)
12. Ishidoh K and Kominami E: Processing and activation of lysosomal proteinases. Biol Chem 383: 1827-1831, 2002. (Pubitemid 36041044)
13. Thomssen C, Schmitt M, Goretzki L, et al: Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer. Clin Cancer Res 7: 741-746, 1995.
14. Harbeck N, Alt U, Berger U, et al: Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy. Clin Cancer Res 9: 2757-2764, 2001. (Pubitemid 32911381)
15. Plebani M, Herszènyi L, Cardin R, et al: Cysteine and serine proteases in gastric cancer. Cancer 76: 367-375, 1995.
16. Sheahan K, Shuja S and Murnane MJ: Cysteine protease activities and tumor development in human colorectal carcinoma. Cancer Res 15: 3809-3814, 1989. (Pubitemid 19197402)
17. Herszényi L, Plebani M, Carraro P, et al: The role of cysteine and serine proteases in colorectal carcinoma. Cancer Res 58: 1624-1630, 1998.
18. Nielsen TO, West RB, Linn SC, et al: Molecular characterisation of soft tissue tumors: a gene expression study. Lancet 359: 1301-1307, 2002. (Pubitemid 34310636)
19. Chi P, Chen Y, Zhang L, et al: ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours. Nature 467: 849-853, 2010.
20. Guinec N, Dalet-Fumeron V, Pagano M, et al: In vitro study of basement membrane degradation by the cysteine proteinases, cathepsins B, B-like and L. Digestion of collagen IV, laminin, fibronectin, and release of gelatinase activities from basement membrane fibronectin. Biol Chem Hoppe Seyler 374: 1135-1146, 1993. (Pubitemid 2023819)
21. Dohchin A, Suzuki JI, Seki H, Masutani M, Shiroto H and Kawakami Y: Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinoma. Cancer 89: 482-487, 2000. (Pubitemid 30640094)
22. Nikitakis NG, Rivera H, Lopes MA, et al: Immunohistochemical expression of angiogenesis-related markers in oral squamous cell carcinomas with multiple metastatic lymph nodes. Am J Clin Pathol 119: 574-586, 2003. (Pubitemid 37046409)
23. DeMatteo R, Lewis J, Leung D, et al: Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231: 51-58, 2000. (Pubitemid 30043939)
24. Joensuu H: Gastrointestinal stromal tumor (GIST). Ann Oncol (Suppl) 10: x280-x286, 2006.
25. Felbou U, Dreier L, Bryant RA, et al: Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J 19: 1187-1194, 2000. (Pubitemid 30151015)
26. Herszényi L, Farinati F, Cardin R, et al: Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer. BMC Cancer 8: 194-205, 2008.